- Country: United Kingdom
Here’s why you need to hit the weights on a GLP-1 - and it might not be for the reason you think
Nearly 30 million Americans are taking the drugs
Nearly 30 million Americans are taking the drugs
Relatos descrevem dois homens hospitalizados após parar o uso do medicamento, mas não comprovam que a interrupção tenha causado os sintomas
Serap Kahriman wollte noch im Frühling Stadtpräsidentin werden. Nun tritt sie ganz aus der städtischen Politik ab.
A közbeszédben sokan egyszerűen fogyasztószerként emlegetik a GLP-1-receptor-agonistákat, valójában azonban eredetileg a 2-es típusú cukorbetegség kezelésére fejlesztették ki ezeket a készítményeket. Mi a hatásuk titka, kinek valók, meddig alkalmazhatók, és mi történik, ha abbahagyjuk?
A new CVS Health analysis linked GLP-1 drugs to fewer hospital stays and ER visits, but insurers still came out paying more overall. CVS says there's a price point where that flips.
As utilization grows and new purchasing channels emerge, US-Rx Care CEO Renzo Luzzati says employers need to assess clinical eligibility, sourcing, and total net cost alongside negotiated discounts. TAMARAC, Fla., Nov. 17, 2026 /PRNewswire/ -- GLP-1 medications are taking a growing share...
- ASC36_37o FDC is a potential first-in-class, once-weekly oral pill candidate targeting all four validated obesity targets. - ASC36_37o FDC supports once-weekly oral dosing, as demonstrated in non-human primates, with half-lives of up to 200 hours (approximately 8.3 days) for ASC36 and...
Clinical trials involved more than 10,000 patients in 15 countries.
This Perspective urges multimodal management of obesity that extends beyond pharmacological treatment to screening, early management, and intensive behavioral therapy across the life course.
This Perspective discusses the actions needed to improve accessibility of glucagon-like peptide-1 (GLP-1) receptor agonists, especially in low- and middle-income countries, after their addition to the World Health Organization’s (WHO) Model List of Essential Medicines.